Gregg Russo - 13 Feb 2025 Form 3/A - Amendment Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief HR Officer
Signature
/s/ Gregg Russo
Issuer symbol
CPRX
Transactions as of
13 Feb 2025
Net transactions value
$0
Form type
3/A - Amendment
Filing time
28 Feb 2025, 17:40:23 UTC
Date Of Original Report
26 Feb 2025
Next filing
24 Nov 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CPRX Common Stock, par value $0.001 per share 0 13 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CPRX Options to purchase common stock 13 Feb 2025 Common Stock 15,000 $15.51 Direct F1
holding CPRX Options to purchase common stock 13 Feb 2025 Common Stock 6,957 $22.90 Direct F2
holding CPRX Options to purchase common stock 13 Feb 2025 Common Stock 20,349 $23.26 Direct F3
holding CPRX Restricted stock units 13 Feb 2025 Common Stock 3,439 Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Derivative Securities vest in three annual tranches beginning on April 8, 2025.
F2 Derivative Securities vest in three annual tranches beginning on February 7, 2026.
F3 Derivative Securities vest in five annual tranches beginning on February 13, 2026.
F4 Shares of common stock will be delivered to the Reporting Person upon vesting.
F5 Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.

Remarks:

This Form 3 is being amended to correct the number of options and restricted stock units that were granted upon the Reporting Person's becoming an executive officer, which were inadvertently reported incorrectly previously.